Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment a...
MEDLANDER iterates its "brain-computer interface + mind-body integration" strategy to broaden growth boundaries through multi-business collaboration
ASML CFO: The company is surprised by the strong demand in the Chinese market for 2025
ASML CEO: The company can become more "flexible."
MEDLANDER: Plans to distribute nearly 30 million in dividends for the first three quarters and change its registered address
MEDLANDER released its performance for the first three quarters, with a net profit attributable to the parent company of 95.9987 million yuan, a year-on-year decrease of 0.07%
MEDLANDER plans to distribute 29.3424 million yuan in cash in the first three quarters of 2025, with no bonus shares or stock dividends